RedHill Biopharma (RDHL) Interest Coverage Ratio Growth (5y) (2017 - 2023)
RedHill Biopharma (RDHL) Interest Coverage Ratio Growth (5y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 38.05% |
| Mar 31, 2023 | -20.22% |
| Dec 31, 2022 | -15.19% |
| Sep 30, 2022 | -51.38% |
| Jun 30, 2022 | -74.29% |
| Mar 31, 2022 | -53.80% |
| Dec 31, 2021 | -5.82% |
| Sep 30, 2021 | -21.00% |
| Jun 30, 2021 | -54.48% |
| Mar 31, 2021 | -76.98% |
| Dec 31, 2020 | -15.33% |
| Sep 30, 2020 | -38.28% |
| Jun 30, 2020 | -12.71% |
| Mar 31, 2020 | 11.76% |
| Dec 31, 2019 | 46.36% |
| Sep 30, 2019 | -40.82% |
| Jun 30, 2019 | -59.15% |
| Mar 31, 2019 | -59.53% |
| Dec 31, 2018 | -14.95% |
| Sep 30, 2018 | -53.33% |